Document:

thct_ex107.htm

EXHIBIT 10.7
  
 MILLENNIUM BLOCKCHAIN INC.
  
 COMMON STOCK PURCHASE AGREEMENT
  
 THIS COMMON STOCK PURCHASE AGREEMENT (the “Agreement”) is made as of July 31, 2018 (the “Execution Date”), by and between Millennium Blockchain Inc., a Nevada corporation (the “Company”), and Robot Cache, S.L., a Spanish sociedad limitada (the “Investor”).
  
 RECITALS
  
 WHEREAS, pursuant to terms and subject to the conditions set forth in this Agreement, the Company desires to sell to the Investor, and the Investor desires to purchase from the Company, shares of the Company’s common stock, $0.001 par value per share (the “Common Stock”), as well as warrants to purchase Common Stock;
  
 NOW, THEREFORE, in consideration of the premises and mutual covenants herein contained, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto agree as follows:
  
 SECTION 1
  
 Purchase and Sale of Shares
  
 1.1 Sale of Shares. Subject to the terms and conditions hereof, the Company will issue and sell to the Investor, and the Investor will purchase from the Company, at the Closing (as defined below), (i) six million (6,000,000) shares (the “Shares”) of Common Stock, and (ii) non-cashless warrants to purchase three million (3,000,000) additional shares of Common Stock on the terms set forth in the Common Stock Purchase Warrants attached hereto as Exhibit C, all in consideration for the right to receive ten million five hundred thirty six thousand three hundred fifteen (10,536,315) cryptographic tokens, known as “IRON,” of the Investor (the “Tokens”).
  
 1.2 Closing. The purchase and sale of the Shares shall take place remotely via the exchange of documents and signatures (the “Closing”) on the first business day following the satisfaction or waiver of the conditions set forth in Section 4 and Section 5 (other than those conditions that by their nature are to be satisfied at or immediately prior to the Closing, but subject to the satisfaction or waiver of those conditions) or at such other date, time and place as the Company and the Investor may agree in writing (the “Closing Date”). At the Closing, the Company will deliver or cause to be delivered to the Investor a copy of the irrevocable instructions to the Company’s transfer agent instructing such transfer agent to issue the Shares into book-entry form to the Investor and, concurrently, the Investor and the Company shall enter into the Simple Agreement for Future Token, attached hereto as Exhibit A (the “SAFT”), which shall grant the Company the right to receive the Tokens on the terms and subject to the conditions set forth in the SAFT.
  
 SECTION 2
  
 Representations and Warranties of the Company
  
 Except as set forth on the Schedule of Exceptions attached hereto as Exhibit B, the Company hereby represents and warrants the following as of the Execution Date:
  
 2.1 Organization and Good Standing and Qualifications. The Company is a corporation duly organized, validly existing and in good standing under the State of Nevada and has all requisite power and authority to own, lease, operate and occupy its properties and to carry on its business as now being conducted. Except as set forth on the Schedule of Exceptions, the Company does not own more than fifty percent (50%) of the outstanding capital stock of or control any other business entity. The Company is duly qualified as a foreign corporation to do business and is in good standing in every jurisdiction in which the nature of the business conducted or property owned or leased by it makes such qualification necessary, other than those in which the failure so to qualify or be in good standing would not have a Material Adverse Effect. For purposes of this Agreement, “Material Adverse Effect” shall mean any event or condition that would reasonably be likely to have a material adverse effect on the business, operations, properties, prospects or financial condition of the Company and its consolidated subsidiaries, taken as a whole, or adversely affect in any material respect the ability of the Company to perform its obligations, or Investor’s rights, under this Agreement.
   	 
	1
	 
 
	 

  
 2.2 Authorization. (i) The Company has the requisite corporate power and authority to enter into and perform its obligations under this Agreement; (ii) the execution and delivery of this Agreement by the Company, the consummation by the Company of the transactions contemplated hereby and thereby and the issuance, sale and delivery of the Shares have been duly authorized by all necessary corporate action, and no further consent or authorization of the Company, its board of directors or its shareholders is required; and (iii) this Agreement has been duly executed and delivered and constitutes a valid and binding obligation of the Company enforceable against the Company in accordance with its terms, except as such enforceability may be limited by applicable bankruptcy, securities, insolvency, or similar laws relating to, or affecting generally the enforcement of, creditors’ rights and remedies, or indemnification or by other equitable principles of general application.
  
 2.3 Valid Issuance of Shares. The issuance of the Shares has been duly authorized by all requisite corporate action. When the Shares are issued, sold and delivered in accordance with the terms of this Agreement for the consideration expressed herein, the Shares will be duly and validly issued and outstanding, fully paid, and nonassessable, and will be free of all liens and restrictions on transfer other than restrictions on transfer under applicable state and federal securities laws and the Investor shall be entitled to all rights accorded to a holder of shares of Common Stock. The Company has reserved a sufficient number of shares of Common Stock for issuance to the Investor in accordance with the Company’s obligations under this Agreement.
  
 2.4 No Conflict. The execution, delivery and performance by the Company of this Agreement and the consummation of the transactions contemplated hereby do not and will not (i) contravene or conflict with the Articles of Incorporation of the Company, (ii) contravene or conflict with or violate any federal, state, local or foreign statute, rule, regulation, judgment, order, writ or decree binding upon or applicable to the Company, (iii) contravene or conflict with or constitute a default (or an event which with notice or lapse of time or both would become a default) under, or give to others any rights of termination, amendment, acceleration or cancellation of, any material contract or other material agreement, mortgage, deed of trust, indenture, note, bond, license, lease agreement, instrument or obligation binding upon or applicable to the Company, or (iv) create or impose a lien, charge or encumbrance on any property of the Company under any agreement or other commitment to which the Company is a party or by which the Company is bound, in the case of each of clauses (iii) and (iv), which would have a Material Adverse Effect.
  
 2.5 Consents. Except for the consents that have been obtained on or prior to the Closing or filings required to be made by the Company with federal or state securities commissions or the OTC Markets Group Inc. (“OTC Market”), no consent, approval, license, order, authorization, registration, declaration or filing with or of any governmental entity or other person is required to be done or obtained by the Company in connection with (i) the execution and delivery by the Company of this Agreement, (ii) the performance by the Company of its obligations under this Agreement, (iii) the consummation by the Company of any of the transactions contemplated by this Agreement, including the issuance and sale of the Shares in accordance with the terms hereof.
  
 2.6 Compliance. The Company is not, and the execution and delivery of this Agreement and the consummation of the transactions contemplated herewith will not cause the Company to be (i) in violation or default of any provision of any instrument, mortgage, deed of trust, loan, contract, or commitment, (ii) in violation of any provision of any judgment, decree, order or obligation to which it is a party or by which it or any of its properties or assets are bound, or (iii) in violation of any federal, state or, to its knowledge, local statute, rule or governmental regulation, in the case of each of clauses (i), (ii) and (iii), which would have a Material Adverse Effect.
   	 
	2
	 
 
	 

  
 2.7 Capitalization. Immediately prior to the Execution Date, a total of 124,035,891 shares of Common Stock are issued and outstanding, 10,000,000 shares of Preferred Stock are authorized, of which 3,000,000 shares are designated Series A Preferred Stock, with 2,060,000 shares of Series A Preferred Stock issued and outstanding, and 165,000 shares of which are designated Series B Preferred Stock, all of which are issued and outstanding. The outstanding shares of capital stock of the Company have been duly and validly issued and are fully paid and nonassessable, were not issued in violation of any preemptive rights or similar rights to subscribe for or purchase securities, and have been issued in compliance with all federal and state securities laws, in each case except as would not reasonably be expected to have a Material Adverse Effect. Except as set forth in the OTC Documents (as defined below), there are no outstanding rights (including, without limitation, preemptive rights), warrants or options to acquire, or instruments convertible into or exchangeable for, any unissued shares of capital stock or other equity interest in the Company, or any contract, commitment, agreement, understanding or arrangement of any kind to which the Company is a party and relating to the issuance or sale of any capital stock of the Company, any such convertible or exchangeable securities or any such rights, warrants or options. Without limiting the foregoing, no preemptive right, co-sale right, right of first refusal, registration right, or other similar right exists with respect to the Shares or the issuance and sale thereof. There are no shareholder agreements, voting agreements or other similar agreements with respect to the voting of the Shares to which the Company is a party or, to the knowledge of the Company, between or among any of the Company’s shareholders.
  
 2.8 OTC Documents, Financial Statements. The Common Stock is currently listed or traded on the OTC Market, and the Company has timely filed all reports, schedules, forms, statements and other documents required to be filed by the Company with the OTC Market pursuant to the reporting requirements for listing as a OTC company (all of the foregoing, including filings incorporated by reference therein, being referred to herein as the “OTC Documents”). The Company is not in violation of the listing requirements of the OTC Market and has no knowledge of any facts that would reasonably lead to delisting or suspension of its Common Stock from the OTC Market in the foreseeable future. As of its date, each OTC Document filed complied in all material respects with the requirements of the OTC Market and the rules and regulations of the OTC Market promulgated thereunder applicable to such document, and, as of its date, after giving effect to the information disclosed and incorporated by reference therein, no such OTC Document contained any untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading. As of their respective dates, the financial statements of the Company included in the OTC Documents filed with the OTC Market, compiled as to form and substance in all material respects with applicable accounting requirements and the published rules and regulations of the OTC Market or other applicable rules and regulations with respect thereto. Such financial statements have been prepared in accordance with generally accepted accounting principles (“GAAP”) applied on a consistent basis during the periods involved (except (i) as may be otherwise indicated in such financial statements or the notes thereto or (ii) in the case of unaudited interim statements, to the extent they may not include footnotes or may be condensed or summary statements), and fairly present in all material respects the financial position of the Company as of the dates thereof and the results of operations and cash flows for the periods then ended (subject, in the case of unaudited statements, to normal year-end audit adjustments).
  
 2.9 Internal Controls and Procedures. The Company maintains adequate disclosure controls and procedures. Such disclosure controls and procedures are effective as of the latest date of management’s evaluation of such disclosure controls and procedures to ensure that all material information required to be disclosed by the Company in the reports that it files or furnishes to the OTC Market is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the OTC Market. The Company maintains a system of internal controls over financial reporting sufficient to provide reasonable assurance that (i) transactions are executed in accordance with management’s general or specific authorizations; and (ii) transactions are recorded as necessary to permit preparation of financial statements in conformity with GAAP.
  
 2.10 Material Adverse Change. Except as disclosed in the OTC Documents, since January 31, 2018, no event or series of events has or have occurred that would, individually or in the aggregate, have a Material Adverse Effect.
  
 2.11 No Undisclosed Liabilities. To the Company’s knowledge, the Company and its consolidated subsidiaries, taken as a whole, do not have any liabilities, obligations, claims or losses (whether liquidated or unliquidated, secured or unsecured, absolute, accrued, contingent or otherwise) that would be required to be disclosed on a balance sheet of the Company and its consolidated subsidiaries (including the notes thereto) in conformity with GAAP and are not disclosed in the OTC Documents, other than those incurred in the ordinary course of the Company’s or its subsidiaries’ respective businesses since January 31, 2018.
  
 2.12 No Undisclosed Events or Circumstances. Except for the transactions contemplated by this Agreement, event or circumstance has occurred or exists with respect to the Company, its subsidiaries, or their respective businesses, properties, operations or financial condition, which, under applicable law, rule or regulation, requires public disclosure or announcement by the Company but which has not been so publicly announced or disclosed and which, individually or in the aggregate, would have a Material Adverse Effect.
   	 
	3
	 
 
	 

  
 2.13 Actions Pending. There is no action, suit, claim, investigation or proceeding pending or, to the knowledge of the Company, threatened against the Company or any subsidiary which questions the validity of this Agreement or the transactions contemplated hereby or any action taken or to be taken pursuant hereto. Except as set forth in the OTC Documents, there is no material action, suit, claim, investigation or proceeding pending or, to the knowledge of the Company, threatened, against or involving the Company, any subsidiary, or any of their respective properties or assets. Except as set forth in the OTC Documents, no material judgment, order, writ, injunction or decree or award has been issued by or, to the knowledge of the Company, requested of any court, arbitrator or governmental agency.
  
 2.14 Compliance with Law. The businesses of the Company and its subsidiaries have been and are presently being conducted in material compliance with all applicable federal, state and local governmental laws, rules, regulations and ordinances. The Company and each of its subsidiaries have all material franchises, permits, licenses, consents and other governmental or regulatory authorizations and approvals necessary for the conduct of its business as now being conducted by it, except for such franchises, permits, licenses, consents and other governmental or regulatory authorizations and approvals, the failure to possess which, individually or in the aggregate, could not reasonably be expected to have a Material Adverse Effect.
  
 2.15 Exemption from Registration, Valid Issuance. Subject to, and in reliance on, the representations, warranties and covenants made herein by the Investor, the issuance and sale of the Shares in accordance with the terms and on the bases of the representations and warranties set forth in this Agreement, may be issued and sold without registration under the Securities Act of 1933, as amended (the “Securities Act”), pursuant to Section 4(a)(2) thereof. The sale and issuance of the Shares pursuant to, and the Company’s performance of its obligations under, this Agreement will not (i) result in the creation or imposition of any liens, charges, claims or other encumbrances upon the Shares or any of the assets of the Company, or (ii) entitle the holders of any outstanding shares of capital stock of the Company to preemptive or other rights to subscribe to or acquire the Shares or other securities of the Company.
  
 2.16 Transfer Taxes. All stock transfer or other taxes (other than income taxes) that are required to be paid in connection with the sale and transfer of the Shares to be sold to Investor hereunder will be, or will have been, fully paid or provided for by the Company and all laws imposing such taxes will be or will have been fully complied with.
  
 2.17 Investment Company. The Company is not, and after giving effect to the offering and sale of the Shares will not be, an “investment company” as defined in the Investment Company Act of 1940, as amended.
  
 2.18 Brokers. No brokers, finders or financial advisory fees or commissions will be payable by the Company or any of its subsidiaries in respect of the transactions contemplated by this Agreement.
  
 SECTION 3
  
 Representations and Warranties of the Investor
  
 The Investor hereby represents and warrants the following as of the Execution Date:
  
 3.1 Experience. The Investor is experienced in evaluating companies such as the Company, has such knowledge and experience in financial and business matters that the Investor is capable of evaluating the merits and risks of the Investor’s perspective investment in the Company, and has the ability to bear the economic risks of the investment.
  
 3.2 Investment. The Investor is acquiring the Shares for investment for the Investor’s own account and not with the view to, or for resale in connection with, any distribution thereof. The Investor understands that the Shares have not been and will not be registered under the Securities Act by reason of a specific exemption from the registration provisions of the Securities Act which depends upon, among other things, the bona fide nature of the investment intent as expressed herein. The Investor further represents that it does not have any contract, undertaking, agreement or arrangement with any person to sell, transfer or grant participation to any third person with respect to any of the Shares.
   	 
	4
	 
 
	 

  
 3.3 Rule 144. The Investor is aware of the provisions of Rule 144 promulgated under the Securities Act which permit limited resale of shares purchased in a private placement subject to the satisfaction of certain conditions. In connection therewith, the Investor acknowledges that the Company will make a notation on its stock books regarding the restrictions on transfers set forth in this Section 3, subject to Section 6.3, and will transfer the Shares on the books of the Company only to the extent not inconsistent herewith and therewith.
  
 3.4 Access to Information. The Investor has received and reviewed information about the Company and has had an opportunity to discuss the Company’s business, management and financial affairs with its management and to review the Company’s facilities. The Investor has had a full opportunity to ask questions of and receive answers from the Company, or any person or persons acting on behalf of the Company, concerning the terms and conditions of an investment in the Shares. The Investor is not relying upon, and has not relied upon, any statement, representation or warranty made by any person, except for the statements, representations and warranties contained in this Agreement.
  
 3.5 Authorization. This Agreement when executed and delivered by the Investor will constitute a valid and legally binding obligation of the Investor, enforceable in accordance with its terms, subject to: (i) judicial principles respecting election of remedies or limiting the availability of specific performance, injunctive relief, and other equitable remedies; and (ii) bankruptcy, insolvency, reorganization, moratorium or other similar laws now or hereafter in effect generally relating to or affecting creditors’ rights.
  
 3.6 Investor Status. The Investor acknowledges that it is an “accredited investor” as defined in Rule 501(a) of Regulation D of the Securities Act, and the Investor shall submit to the Company such further assurances of such status as may be reasonably requested by the Company.
  
 3.8 No Conflicts. The execution, delivery and performance by the Investor of this Agreement do not and will not (i) contravene or conflict with the organizational documents of the Investor, (ii) contravene or conflict with or constitute a default under any material provision of any law binding upon or applicable to the Investor or (iii) contravene or conflict with or constitute a default under any material contract or other material agreement, judgment, order, writ, injunction, citation, award or decree binding upon or applicable to the Investor.
  
 3.9 Consent. No consent, approval, license, order, authorization, registration, declaration or filing with or of any governmental entity or other person is required to be done or obtained by the Investor in connection with (i) the execution and delivery by the Investor of this Agreement, (ii) the performance by the Investor of its obligations under this Agreement or (iii) the consummation by the Investor of any of the transactions contemplated by this Agreement.
  
 SECTION 4
  
 Conditions to Investor’s Obligations at Closing
  
 The obligations of the Investor under this Agreement are subject to the fulfillment on or before the Closing of each of the following conditions, any of which may be waived in writing by the Investor (except to the extent not permitted by law):
  
 4.1 No Injunction, etc. No preliminary or permanent injunction or other binding order, decree or ruling issued by a court or governmental agency shall be in effect which shall have the effect of preventing the consummation of the transactions contemplated by this Agreement. No action or claim shall be pending before any court or quasi- judicial or administrative agency of any federal, state, local or foreign jurisdiction or before any arbitrator wherein an unfavorable injunction, judgment, order, decree, ruling or charge would be reasonably likely to (i) prevent consummation of any of the transactions contemplated by this Agreement, (ii) cause any of the transactions contemplated by this Agreement to be rescinded following consummation or (iii) have the effect of making illegal the purchase of, or payment for, any of the Shares by the Investor.
   	 
	5
	 
 
	 

  
 4.2 Representations and Warranties. The representations and warranties of the Company contained in Section 2 shall have been true and correct in all material respects (except for such representations and warranties that are qualified by “materiality” or “Material Adverse Effect” which shall be true and correct in all respects) on and as of the Closing with the same effect as though such representations and warranties had been made on and as of the Closing.
  
 4.3 Performance. The Company shall have performed and complied with all covenants, agreements, obligations and conditions contained in this Agreement that are required to be performed or complied with by it on or before the Closing.
  
 4.5 Securities Laws. The offer and sale of the Shares to the Investor pursuant to this Agreement shall be exempt from the registration requirements of the Securities Act and the registration and/or qualification requirements of all applicable state securities laws.
  
 4.6 Authorizations. All authorizations, approvals or permits, if any, of any governmental authority or regulatory body that are required in connection with the lawful issuance and sale of the Shares pursuant to this Agreement shall have been duly obtained and shall be effective on and as of the Closing.
  
 SECTION 5
  
 Conditions to the Company’s Obligations at Closing
  
 The obligations of the Company to the Investor under this Agreement are subject to the fulfillment on or before the Closing of each of the following conditions by the Investor:
  
 5.1 Representations and Warranties. The representations and warranties of the Investor contained in Section 3 shall be true and correct in all material respects (except for such representations and warranties that are qualified by materiality which shall be true and correct in all respects) on and as of the Closing with the same effect as though such representations and warranties had been made on and as of the Closing.
  
 5.2 Securities Law Compliance. The offer and sale of the Shares to the Investor pursuant to this Agreement shall be exempt from the registration requirements of the Securities Act and the registration and/or qualification requirements of all applicable state securities laws.
  
 5.3 Authorization. All authorizations, approvals or permits, if any, of any governmental authority or regulatory body that are required in connection with the lawful issuance and sale of the Shares pursuant to this Agreement shall have been duly obtained and shall be effective on and as of the Closing.
  
 SECTION 6
  
 Resales; Covenants
  
 6.1 Participation Right.
  
 (a) The Investor hereby grants the Company the right of first refusal to purchase up to the Company Investment Share (as defined below) of equity securities (the “Equity Securities”) issued in the Investor’s next round of Equity Financing (as defined below). However, the Company will have no right to purchase any Equity Securities if the Company cannot demonstrate to the Investor’s reasonable satisfaction that the Company is at the time of the proposed issuance of the Equity Securities an “accredited investor” as such term is defined in Regulation D under the Securities Act.
   	 
	6
	 
 
	 

  
 (b) If the Investor proposes to undertake an issuance of Equity Securities, it shall give notice to the Company of its intention to issue Equity Securities (the “Notice”), describing the type of Equity Securities and the price and the general terms upon which the Company proposes to issue the Equity Securities. The Company will have ten (10) days from the date of the Notice to agree in writing to purchase the Company’s share of such Equity Securities for the price and upon the general terms specified in the Notice by giving written notice to the Company and stating therein the quantity of Equity Securities to be purchased (not to exceed the Company Investment Share, unless agree to in writing by the Investor).
  
 (c) In connection with any issuance of Equity Securities by the Investor to the Company pursuant to this Section 6.1, the Company will execute and deliver to the Investor all transaction documents related to the Equity Financing; provided, that these documents are the same or similar to the documents to be entered into with other purchasers of Equity Securities.
  
 (c) “Equity Financing” means a bona fide transaction or series of transactions pursuant in which the Investor issues and sells capital stock with the principal purpose of raising capital (other than in connection with a sale of tokens or a right to receive tokens).
  
 (d) “Company Investment Share” means Equity Securities representing three percent (3.00%) of the Investor’s total outstanding shares of capital stock immediately following the Equity Financing.
  
 6.2 Rule 144 Reporting. With a view to making available to the Investor the benefits of certain rules and regulations of the Securities and Exchange Commission (the “Commission”) that may permit the sale of the Shares to the public without registration and, in each case, for so long as the Investor holds Shares that are not freely transferable without restriction under the Securities Act (including the current public information requirement under Rule 144), the Company agrees to use commercially reasonable efforts to:
  
 (a) Make and keep public information available, as those terms are understood and defined in Rule 144 promulgated under the Securities Act;
  
 (b) File with the OTC Market in a timely manner all reports and other documents required of the Company by the OTC Market; and
  
 (c) Furnish the Investor forthwith upon request (i) a written statement by the Company as to its compliance with the public information requirements of said Rule 144, (ii) a copy of the most recent annual or quarterly report of the Company, and (iii) such other reports and documents as may be reasonably requested in availing the Investor of any rule or regulation of the Commission permitting the sale of any such securities without registration.
  
 6.3 Restrictive Legend. The Investor agrees to the imprinting on any stock certificates, so long as is required by this Section 6, of a restrictive legend in substantially the following form:
  
 “THE SECURITIES EVIDENCED OR CONSTITUTED HEREBY HAVE BEEN ISSUED WITHOUT REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”) AND MAY NOT BE SOLD, OFFERED FOR SALE, TRANSFERRED, PLEDGED OR HYPOTHECATED WITHOUT REGISTRATION UNDER THE ACT UNLESS EITHER (i) THE COMPANY HAS RECEIVED AN OPINION OF COUNSEL, IN FORM AND SUBSTANCE REASONABLY SATISFACTORY TO THE COMPANY, TO THE EFFECT THAT REGISTRATION IS NOT REQUIRED IN CONNECTION WITH SUCH DISPOSITION OR (ii) THE SALE OF SUCH SECURITIES IS MADE PURSUANT TO SECURITIES AND EXCHANGE COMMISSION RULE 144.”
   	 
	7
	 
 
	 

  
 The legend set forth in this Section 6.3 and the related notation in the Company’s register of shareholders shall be removed and the Company shall issue a certificate without such legend or any other legend to the holder of the Shares, if (i) the Shares are registered for resale under the Securities Act, (ii) the Shares are sold or transferred in compliance with to Rule 144 and the Company has received such customary certifications and other information as it shall have reasonably requested to demonstrate compliance of such transfer or sale with Rule 144, or (iii) the Shares are eligible for sale under Rule 144, without the requirement for the Company to be in compliance with the current public information required under Rule 144. Following Rule 144 becoming available for the resale of Shares, without the requirement for the Company to be in compliance with the current public information required under Rule 144, the Company shall (at the Company’s expense), upon the written request of Investor, cause its counsel to issue to the Company’s transfer agent a legal opinion authorizing the issuance of a certificate representing the Shares without any restrictive or other legends, if requested by such transfer agent.
  
 6.4 Listing. Promptly following the date hereof, the Company shall prepare and submit to the OTC Market a listing application covering the Shares, together with all other documents required by the OTC Market to be submitted in support thereof.
  
 6.5 Further Assurances. Each of the Investor and the Company shall execute such further documents and shall take, or shall cause to be taken, such further actions as may be reasonably required to carry out the provisions of this Agreement and give effect to the transactions contemplated hereby.
  
 SECTION 7
  
 Indemnification
  
 7.1 Each party (an “Indemnifying Party”) hereby indemnifies and holds harmless the other party, such other party’s respective officers, directors, employees, consultants, representatives and advisers, and any and all Affiliates of the foregoing (each of the foregoing, an “Indemnified Party”) from and against all losses, liabilities, costs, damages and expense (including reasonable legal fees and expenses) (collectively, “Losses”) suffered or incurred by any such Indemnified Party to the extent arising from, connected with or related to (a) breach of any representation or warranty of such Indemnifying Party in this Agreement; and (b) breach of any covenant or undertaking of any Indemnifying Party in this Agreement. If an event or omission (including, without limitation, any claim asserted or action or proceeding commenced by a third party) occurs which an Indemnified Party asserts to be an indemnifiable event pursuant to this Section 7, the Indemnified Party will provide written notice to the Indemnifying Party, setting forth the nature of the claim and the basis for indemnification under this Agreement. The Indemnified Party will give such written notice to the Indemnifying Party immediately after it becomes aware of the existence of any such event or occurrence. Such notice will be a condition precedent to any obligation of the Indemnifying Party to act under this Agreement but will not relieve it of its obligations under the indemnity except to the extent that the failure to provide prompt notice as provided in this Agreement prejudices the Indemnifying Party with respect to the transactions contemplated by this Agreement and to the defense of the liability. In case any such action is brought by a third party against any Indemnified Party and it notifies the Indemnifying Party of the commencement thereof, the Indemnifying Party will be entitled to participate therein and, to the extent that it wishes, to assume the defense and settlement thereof with counsel reasonably selected by it and, after notice from the Indemnifying Party to the Indemnified Party of such election so to assume the defense and settlement thereof, the Indemnifying Party will not be liable to the Indemnified Party for any legal expenses of other counsel or any other expenses subsequently incurred by such Indemnified Party in connection with the defense thereof, provided, however, that an Indemnified Party shall have the right to employ separate counsel at the expense of the Indemnifying Party if (i) the employment thereof has been specifically authorized in writing by the Indemnifying Party; or (ii) representation of both parties by the same counsel would be inappropriate due to actual or potential conflicts of interests between such parties (which such judgment shall be made by the Indemnified Party in good faith after consultation with counsel). The Indemnified Party agrees to cooperate fully with (and to provide all relevant documents and records and make all relevant personnel available to) the Indemnifying Party and its counsel, as reasonably requested, in the defense of any such asserted claim at no additional cost to the Indemnifying Party. No Indemnifying Party will consent to the entry of any judgment or enter into any settlement with respect to any such asserted claim without the prior written consent of the Indemnified Party, not to be unreasonably withheld or delayed, (A) if such judgment or settlement does not include as an unconditional term thereof the giving by each claimant or plaintiff to each Indemnified Party of a release from all liability in respect to such claim or (B) if, as a result of such consent or settlement, injunctive or other equitable relief would be imposed against the Indemnified Party or such judgment or settlement could materially and adversely affect the business, operations or assets of the Indemnified Party. No Indemnified Party will consent to the entry of any judgment or enter into any settlement with respect to any such asserted claim without the prior written consent of the Indemnifying Party, not to be unreasonably withheld or delayed. If an Indemnifying Party makes a payment with respect to any claim under the representations or warranties set forth herein and the Indemnified Party subsequently receives from a third party or under the terms of any insurance policy a sum in respect of the same claim, the receiving party will repay to the other party such amount that is equal to the sum subsequently received.
   	 
	8
	 
 
	 

  
 7.2 Limitations on Liability. No party hereto shall be liable for any punitive or special damages under this Section 7 (and no claim for indemnification hereunder shall be asserted) as a result of any breach or violation of any covenant or agreement of such party (including under this Section 7) in or pursuant to this Agreement.
  
 7.3 Exclusive Remedy. The rights of the parties hereto pursuant to (and subject to the conditions of) this Section 7 shall be the sole and exclusive remedy of the parties hereto and their respective Affiliates with respect to any Losses (whether based in contract, tort or otherwise) resulting from or relating to any breach of the representations, warranties covenants and agreements made under this Agreement or any certificate, document or instrument delivered hereunder, and each party hereto hereby waives, to the fullest extent permitted under applicable law, and agrees not to assert after Closing, any other claim or action in respect of any such breach. Notwithstanding the foregoing, claims for common law fraud shall not be waived or limited in any way by this Section 7.
  
 7.4 Affiliates. For all purposes of this Agreement, the term “Affiliate” means, with respect to a specified entity, an entity that directly or indirectly through one or more intermediaries, is controlled by the entity, in each case where the term “control” means possession, directly or indirectly, of the power to direct or cause the direction of the management and policies of an entity, whether through ownership of voting securities, by contract interest or otherwise.
  
 SECTION 8
  
 Miscellaneous
  
 8.1 Governing Law. This Agreement shall be governed in all respects by the laws of California as applied to agreements entered into and performed entirely in the State of California by residents thereof.
  
 8.2 Survival. The representations, warranties, covenants and agreements made herein shall survive any investigation made by the Investor and the Closing until the expiration of the applicable statute of limitations.
  
 8.3 Successors, Assigns. Except as otherwise provided herein, the provisions hereof shall inure to the benefit of, and be binding upon, the successors, assigns, heirs, executors and administrators of the parties hereto. This Agreement may not be assigned by either party without the prior written consent of the other; except that either party may assign this Agreement to an Affiliate of such party or to any third party that acquires all or substantially all of such party’s business, whether by merger, sale of assets or otherwise.
  
 8.4 Notices. All notices and other communications required or permitted hereunder shall be in writing and shall be sent by electronic mail or mailed by registered or certified mail, postage prepaid, return receipt requested, or otherwise delivered by hand or by messenger, addressed
  
 if to the Investor, at the following address: 
  
 Robot Cache, S.L.
 Calle El Pilar No. 5
 Edificio Peceno Local 9
 38002 Santa Cruz se Tenerife, Spain 
 Attention: Lee Jacobson, CEO
 E-mail: lee@robotcache.com
   	 
	9
	 
 
	 

  
 if to the Company, at the following address: 
  
 Millennium Blockchain Inc.
 11700 W. Charleston Blvd., Suite 73 
 Las Vegas, Nevada 89135 
 Attention: Brandon Romanek, CEO 
 E-mail: brandon@mblockchain.io
  
 or at such other address as one party shall have furnished to the other party in writing. All notices and communications under this Agreement shall be deemed to have been duly given (i) when delivered by hand, if personally delivered, (ii) when received by a recipient, if sent by email, or (iii) one business day following sending within the United States by overnight delivery via commercial one-day overnight courier service.
  
 8.5 Expenses. Each of the Company and the Investor shall bear its own expenses and legal fees incurred on its behalf with respect to this Agreement and the transactions contemplated hereby.
  
 8.6 Finder’s Fees. Each of the Company and the Investor shall indemnify and hold the other harmless from any liability for any commission or compensation in the nature of a finder’s fee, placement fee or underwriter’s discount (including the costs, expenses and legal fees of defending against such liability) for which the Company or the Investor, or any of its respective partners, employees, or representatives, as the case may be, is responsible.
  
 8.7 Counterparts. This Agreement may be executed in counterparts, each of which shall be enforceable against the party actually executing the counterpart, and all of which together shall constitute one instrument. Delivery of an executed counterpart of a signature page of this Agreement in Portable Document Format (PDF) or by facsimile transmission shall be effective as delivery of a manually executed original counterpart of this Agreement.
  
 8.8 Severability. In the event that any provision of this Agreement becomes or is declared by a court of competent jurisdiction to be illegal, unenforceable or void, this Agreement shall continue in full force and effect without said provision; provided that no such severability shall be effective if it materially changes the economic benefit of this Agreement to any party.
  
 8.9 Entire Agreement. This Agreement, including the exhibits and schedules attached hereto and thereto, constitute the full and entire understanding and agreement among the parties with regard to the subjects hereof and thereof. No party shall be liable or bound to any other party in any manner with regard to the subjects hereof or thereof by any warranties, representations or covenants except as specifically set forth herein or therein.
  
 8.10 Waiver. The failure of either party to assert a right hereunder or to insist upon compliance with any term or condition of this Agreement shall not constitute a waiver of that right or excuse a similar subsequent failure to perform any such term or condition by the other party. None of the terms, covenants and conditions of this Agreement can be waived except by the written consent of the party waiving compliance.
  
 [Signature Page Follows]
   	 
	10
	 
 
	 

  
 IN WITNESS WHEREOF, the parties have executed this Common Stock Purchase Agreement as of the date first set forth above.
  
 	  
	 COMPANY
  
 MILLENNIUM BLOCKCHAIN INC.
	  

	  
	  
	  
	  

	  
	 By:
	 
	  

	  
	 Name:
	 Brandon Romanek
	  

	  
	 Title:
	 Chief Executive Officer
	  

	  
	  
	  
	  

	  
	 INVESTOR
  
 ROBOT CACHE, S.L.
	  

	  
	  
	  
	  

	  
	 By:
	 
	  

	  
	 Name:
	 Lee Jacobson
	  

	  
	 Title:
	 Chief Executive Officer
	  

   	 
	11
	 
 
	 

  
 EXHIBIT A
  
 SAFT
  
  
  	 
	 

	 

	 

  
  
  	 
	 

	 

	 

  
  
  	 
	 

	 

	 

  
  
  	 
	 

	 

	 

  
  
  	 
	 

	 

	 

  
  
  	 
	 

	 

	 

  
  
  	 
	 

	 

	 

  
  
  	 
	 

	 

	 

  
  
  	 
	 

	 

	 

  
  
  	 
	 

	 

	 

  
  
  	 
	 

	 

	 

  
  
  	 
	 

	 

	 

  
  
  	 
	 

	 

	 

  
  
  	 
	 

	 

	 

  
  
  	 
	 

	 

	 

  
  
  	 
	 

	 

	 

  
  
  	 
	 

	 

	 

  
  
  	 
	 

	 

	 

  
  
  	 
	 

	 

	 

  
  
  	 
	 

	 

	 

  
  
  
  
  
  
  
  	 
	
	 
 
	 

  
 EXHIBIT B
  
 SCHEDULE OF EXCEPTIONS
   
  
  
  
  
  	 
	
	 
 
	 

  
 EXHIBIT C
  
 COMMON STOCK PURCHASE WARRANTSEX-4.2

 Exhibit 4.2 

 
  

GENERAL MOTORS FINANCIAL COMPANY, INC., 

AS ISSUER 
  

 
 3.550% SENIOR
NOTES DUE 2022 
  
  

THIRTY-FIFTH SUPPLEMENTAL INDENTURE 

Dated as of April 8, 2019 

to 
 INDENTURE 

Dated as of October 13, 2015 
  

 

WELLS FARGO BANK, NATIONAL ASSOCIATION, 

AS TRUSTEE 

 TABLE OF CONTENTS 

 

					
	 	  	Page	 
		
	 ARTICLE 1 DEFINITIONS AND INCORPORATION BY REFERENCE
	  	 	1	 
		
	 Section 1.01 Definitions.
	  	 	1	 
	 Section 1.02 Incorporation by Reference of Trust Indenture Act.
	  	 	5	 
	 Section 1.03 Rules of Construction.
	  	 	5	 
	 Section 1.04 Relationship with Base Indenture.
	  	 	6	 
		
	 ARTICLE 2 THE NOTES
	  	 	6	 
		
	 Section 2.01 Establishment, Form and Dating.
	  	 	6	 
	 Section 2.02 Registrar and Paying Agent.
	  	 	6	 
		
	 ARTICLE 3 REDEMPTION OF NOTES
	  	 	7	 
		
	 Section 3.01 Optional Redemption.
	  	 	7	 
	 Section 3.02 Mandatory Redemption.
	  	 	7	 
		
	 ARTICLE 4 COVENANTS
	  	 	7	 
		
	 Section 4.01 Liens.
	  	 	7	 
	 Section 4.02 Corporate Existence.
	  	 	7	 
		
	 ARTICLE 5 DEFEASANCE
	  	 	8	 
		
	 ARTICLE 6 NO GUARANTEES
	  	 	8	 
		
	 ARTICLE 7 MISCELLANEOUS
	  	 	8	 
		
	 Section 7.01 Governing Law.
	  	 	8	 
	 Section 7.02 Successors.
	  	 	8	 
	 Section 7.03 Severability.
	  	 	8	 
	 Section 7.04 Counterpart Originals.
	  	 	8	 
	 Section 7.05 Table of Contents, Headings, Etc.
	  	 	9	 

  
 i 

 This THIRTY-FIFTH SUPPLEMENTAL INDENTURE (this “Supplemental Indenture”),
dated as of April 8, 2019, between General Motors Financial Company, Inc., a Texas corporation (the “Company”), and Wells Fargo Bank, National Association, as trustee (the “Trustee”). 

WHEREAS, the Company has heretofore executed and delivered to the Trustee an indenture, dated as of October 13, 2015 (as amended or
supplemented to the date hereof, the “Base Indenture” and, together with this Supplemental Indenture, the “Indenture), between the Company and the Trustee, providing for the issuance by the Company from time to time of
one or more series of Securities; 
 WHEREAS, the Company has duly authorized the execution and delivery of this Supplemental Indenture to
provide for the issuance of its 3.550% senior notes due 2022 (the “Notes”); 
 WHEREAS, the Company desires and has
requested the Trustee to join with it in the execution and delivery of this Supplemental Indenture in order to supplement the Base Indenture and to add covenants to and remove covenants from the Base Indenture with respect to the Notes as and to the
extent set forth herein to provide for the issuance and the terms of the Notes; and 
 WHEREAS, all things necessary to make this
Supplemental Indenture a valid indenture and agreement of the Company according to its terms have been done. 
 NOW, THEREFORE: 

In consideration of the premises and the purchase of the Notes by the Holders thereof, the Company and the Trustee mutually covenant and agree
for the equal and proportionate benefit of all Holders from time to time of the Notes as follows. 
 ARTICLE 1 

DEFINITIONS AND INCORPORATION BY REFERENCE 

Section 1.01 Definitions. 

Certain terms used principally in certain Articles hereof are defined in those Articles. Capitalized terms used but not defined in this
Supplemental Indenture shall have the meaning ascribed to them in the Base Indenture or in this Article. In the event of any conflict between any term defined in the Base Indenture and this Supplemental Indenture, the defined terms in this
Supplemental Indenture shall govern and control. 
 “Additional Notes” means any additional Notes issued under the
Indenture as part of the same series as the Notes. 
 “Bank Lines” means, with respect to the Company or any of its
Restricted Subsidiaries, one or more debt facilities with banks or other lenders providing for revolving credit loans and/or letters of credit. 

“Base Indenture” has the meaning assigned to it in the recitals hereto, as amended, supplemented or otherwise modified from
time to time in accordance with the terms thereof. 
 “Board of Directors” means the Company’s board of directors or
any committee of that board duly authorized to act generally or in any particular respect for the Company under the Indenture. 

“Business Day” means any day other than a Saturday, a Sunday or a day on which banking institutions in the City of New York
are authorized or obligated by law, regulation or executive order to remain closed. 
 “Comparable Treasury Issue” means
the United States Treasury security or securities selected by the Quotation Agent as having an actual or interpolated maturity comparable to the remaining term of the Notes that would be utilized, at the time of selection and in accordance with
customary financial practice, in pricing new issues of corporate debt securities of comparable maturity to the remaining term of the Notes. 

 “Comparable Treasury Price” means, with respect to any redemption date,
(i) the average of four Reference Treasury Dealer Quotations for such redemption date, after excluding the highest and lowest such Reference Treasury Dealer Quotations, or (ii) if the Quotation Agent obtains fewer than four such Reference
Treasury Dealer Quotations, the average of all such quotations. 
 “Consolidated Net Tangible Assets” means the aggregate
amount of assets (less applicable reserves and other properly deductible items) after deducting therefrom all current liabilities and all goodwill, trade names, trademarks, unamortized debt discounts and expense and other like intangibles of the
Company and its consolidated Subsidiaries, all as set forth in the most recent balance sheet of the Company and its consolidated Subsidiaries prepared in accordance with GAAP. 

“Credit Enhancement Agreements” means, collectively, any documents, instruments, guarantees or agreements entered into
by the Company, any of its Restricted Subsidiaries or any Receivables Entity for the purpose of providing credit support for one or more Receivables Entities or any of their respective securities, debt instruments, obligations or other Indebtedness.

 “GAAP” means generally accepted accounting principles in the United States of America as in effect from time to time,
including those set forth in the opinions and pronouncements of the Accounting Principles Board of the American Institute of Certified Public Accountants and statements and pronouncements of the Financial Accounting Standards Board or in such other
statements by such other entity as have been approved by a significant segment of the accounting profession, consistently applied. 

“Global Notes” means, individually and collectively, each certificated Note deposited with or on behalf of and registered in
the name of the Depositary or its nominee, substantially in the form of Exhibit A hereto and which has the “Schedule of Exchanges of Interests in the Global Note” attached thereto. As of the date of this Supplemental Indenture, all
of the Notes are represented by one or more Global Notes. 
 “Hedging Obligations” means, with respect to any Person, the
obligations of such Person under (i) interest rate swap agreements, interest rate cap agreements and interest rate collar agreements and (ii) other agreements or arrangements designed to protect such Person against fluctuations in interest
or currency exchange rates. 
 “Indebtedness” means, with respect to any Person, without duplication, any indebtedness of
such Person in respect of borrowed money or evidenced by bonds, notes, debentures or similar instruments or letters of credit (or reimbursement agreements in respect thereof), except any such balance that constitutes an accrued expense or trade
payable, if and to the extent any of the foregoing indebtedness (other than letters of credit) would appear as a liability upon a balance sheet of such Person prepared in accordance with GAAP (but does not include contingent liabilities which appear
only in a footnote to a balance sheet). 
 “Indenture” has the meaning assigned to it in the preamble hereto. 

“Initial Notes” means the first $1,250,000,000 aggregate principal amount of the Notes issued under the Indenture on the date
hereof. 
 “Interest Payment Date” means each day on which interest on the Notes will be paid, which will be semi-annually
in arrears on January 8 and July 8 of each year, commencing on July 8, 2019, and at maturity. 
 “Non-Domestic Entity” means a Person not organized or existing under the laws of the United States, any state thereof or the District of Columbia. 

“Notes” has the meaning assigned to it in the recitals hereto. For purposes of the Indenture, all references to the notes to
be issued or authenticated upon transfer or replacement of or in exchange for Notes shall be deemed to refer to Notes. In addition, unless the context otherwise requires, all references to the “Notes” shall include the Initial Notes and
any Additional Notes. 

  
 2 

 “Permitted Liens” means: 

 

	 	(i)	 Liens existing on the date of the Base Indenture; 

 

	 	(ii)	 Liens to secure securities, debt instruments or other Indebtedness of one or more Receivables Entities or
guarantees thereof; 

  

	 	(iii)	 Liens to secure Indebtedness under a Residual Funding Facility or guarantees thereof; 

 

	 	(iv)	 Liens to secure Indebtedness and other obligations (including letter of credit indemnity obligations and
obligations relating to expenses with respect to debt facilities) under Bank Lines or guarantees thereof; 

  

	 	(v)	 Liens on spread accounts, reserve accounts and other credit enhancement assets, Liens on the Capital Stock of
Subsidiaries of the Company, substantially all of the assets of which are spread accounts, reserve accounts and/or other credit enhancement assets, and Liens on interests in one or more Receivables Entities, in each case incurred in connection with
Credit Enhancement Agreements, Residual Funding Facilities or issuances of securities, debt instruments or other Indebtedness by a Receivables Entity; 

  

	 	(vi)	 Liens on property existing at the time of acquisition of such property (including properties acquired through
merger or consolidation); 

  

	 	(vii)	 Liens securing Indebtedness incurred to finance the construction or purchase of property of the Company or any
of its Subsidiaries (but excluding Capital Stock of another Person); provided that any such Lien may not extend to any other property owned by the Company or any of its Subsidiaries at the time the Lien is incurred, and the Indebtedness
secured by the Lien may not be incurred more than 180 days after the later of the acquisition or completion of construction of the property subject to the Lien; 

 

	 	(viii)	 Liens securing Hedging Obligations; 

 

	 	(ix)	 Liens to secure any Refinancing Indebtedness incurred to refinance any Indebtedness and all other obligations
secured by any Lien referred to in the foregoing clause (i); provided that such new Lien shall be limited to all or part of the same property or type of property that secured the original Lien, and the Indebtedness secured by such Lien at
such time is not increased to any amount greater than the outstanding principal amount or, if greater, committed amount of the Indebtedness described under clause (i) of this definition at the time the original Lien became a Permitted Lien;

  

	 	(x)	 Liens in favor of the Company or any of its Subsidiaries; 

 

	 	(xi)	 Liens of the Company or any Restricted Subsidiary of the Company with respect to obligations that do not exceed
five percent of Consolidated Net Tangible Assets; 

  

	 	(xii)	 Liens to secure the performance of statutory obligations, surety or appeal bonds, performance bonds or other
obligations of a like nature incurred in the ordinary course of business (including, without limitation, landlord Liens on leased properties); 

  

	 	(xiii)	 Liens for taxes, assessments or governmental charges or claims that are not yet delinquent or that are being
contested in good faith by appropriate proceedings; provided, that any reserve or other appropriate provision as shall be required in conformity with GAAP shall have been made therefor; 

 

	 	(xiv)	 Liens imposed by law or regulation, such as carriers’, warehousemen’s, materialmen’s,
repairmen’s and mechanics’ and similar Liens, in each case for sums not yet overdue for 

  
 3 

	 	
a period of more than 30 days or that are being contested in good faith by appropriate proceedings or other Liens arising out of judgments or awards against such Person with respect to which such
Person shall then be proceeding with an appeal or other proceedings for review; provided, that any reserve or other appropriate provision as shall be required in conformity with GAAP shall have been made therefor; 

 

	 	(xv)	 Liens related to minor survey exceptions, minor encumbrances, ground leases, easements or reservations of, or
rights of others for, licenses, rights-of-way, servitudes, sewers, electric lines, drains, telegraph and telephone and cable television lines, gas and oil pipelines and
other similar purposes, or zoning, building codes or other restrictions (including, without limitation, minor defects or irregularities in title and similar encumbrances) as to the use of real properties or Liens incidental to the conduct of the
business of such Person or to the ownership of its properties which were not incurred in connection with Indebtedness and which do not in the aggregate materially adversely affect the value of said properties or materially impair their use in the
operation of the business of such Person; 

  

	 	(xvi)	 Liens on equipment of the Company or any of its Restricted Subsidiaries granted in the ordinary course of
business; 

  

	 	(xvii)	 deposits made or other security provided to secure liabilities to insurance carriers under insurance or
self-insurance arrangements in the ordinary course of business; 

  

	 	(xviii)	 purported Liens evidenced by filings of precautionary UCC financing statements relating solely to operating
leases of personal property; 

  

	 	(xix)	 Liens evidenced by UCC financing statement filings (or similar filings) regarding or otherwise arising under
leases entered into by the Company or any Restricted Subsidiary in the ordinary course of business; (xx) Liens on accounts, payment intangibles, chattel paper, instruments and/or other Receivables granted in connection with sales of any of such
assets; and 

  

	 	(xxi)	 Liens on Receivables and related assets and proceeds thereof arising in connection with a Permitted Receivables
Financing. 

 “Permitted Receivables Financing” means any facility, arrangement, transaction or agreement
(i) pursuant to which the Company or any Restricted Subsidiary finances the acquisition or origination of Receivables with, or sells Receivables that it has acquired or originated to, a third party on terms that the Board of Directors has
concluded are customary and market-standard, and/or (ii) that grants Liens to, or permits filings of precautionary UCC financing statements by, the third party against the Company or its Restricted Subsidiaries, as applicable, under such
facility, arrangement, transaction or agreement relating to the subject Receivables, related assets and/or proceeds. 
 “Quotation
Agent” means a Reference Treasury Dealer appointed by the Company. 
 “Receivable” means each of the following:
(i) any right to payment of a monetary obligation, including, without limitation, any promissory note, financing agreement, installment sale contract, lease contract, insurance or service contract, or any credit, debit or charge card
receivable, and (ii) any assets related to such receivables, including, without limitation, any collateral securing, or property leased under, such receivables. 

“Receivables Entity” means each of the following: (i) any Person (whether or not a Subsidiary of the Company)
established for the purpose of transferring or holding Receivables or issuing securities, debt instruments or other Indebtedness backed by Receivables and/or Receivable-backed securities, regardless of whether such Person is an issuer of securities,
debt instruments or other Indebtedness; and (ii) any Subsidiary of the Company formed exclusively for the purpose of satisfying the requirements of Credit Enhancement Agreements, regardless of whether such Person is an issuer of securities,
debt instruments or other Indebtedness. 

  
 4 

 “Redemption Price” has the meaning assigned to it in Section 3.01(b)
hereto. 
 “Reference Treasury Dealer” means (i) any of BNP Paribas Securities Corp., Citigroup Global Markets Inc.,
Deutsche Bank Securities Inc., Mizuho Securities USA LLC and TD Securities (USA) LLC and their respective successors; provided, however, that if any of the foregoing shall cease to be a primary U.S. government securities dealer in New
York City (a “Primary Treasury Dealer”), the Company will substitute therefor another Primary Treasury Dealer; and (ii) any other Primary Treasury Dealer(s) selected by the Company. 

“Reference Treasury Dealer Quotations” means, with respect to each Reference Treasury Dealer and any redemption date, the
average, as determined by the Quotation Agent, of the bid and asked prices for the Comparable Treasury Issue (expressed in each case as a percentage of its principal amount) quoted in writing to the Quotation Agent by such Reference Treasury Dealer
at 5:00 p.m., New York City time, on the third Business Day preceding such redemption date. 
 “Refinancing Indebtedness”
means any Indebtedness of the Company or any of its Restricted Subsidiaries issued in exchange for, or the net proceeds of which are used to extend, refinance, renew, replace, defease or refund, other Indebtedness of the Company or any of its
Restricted Subsidiaries. 
 “Remaining Scheduled Payments” means the remaining scheduled payments of principal of and
interest on the Notes called for redemption that would be due after the related redemption date but for that redemption (exclusive of interest accrued and unpaid as of the date of redemption). 

“Residual Funding Facility” means any funding arrangement with a financial institution or institutions or other lenders or
purchasers under which advances are made to the Company or any Subsidiary based upon residual, subordinated or retained interests in Receivables Entities or any of their respective securities, debt instruments or other Indebtedness. 

“Restricted Subsidiary” means any Subsidiary of the Company that is not a Receivables Entity or Non-Domestic Entity. 
 “Supplemental Indenture” has the meaning assigned to it in the
preamble hereto. 
 “Treasury Rate” means, with respect to any redemption date, the rate per annum equal to the semi-annual
equivalent yield to maturity of the Comparable Treasury Issue, calculated by the Quotation Agent on the third Business Day preceding the redemption date, assuming a price for the Comparable Treasury Issue (expressed as a percentage of its principal
amount) equal to the Comparable Treasury Price for such redemption date. 
 “Trustee” means Wells Fargo Bank, National
Association, until a successor replaces it in accordance with the applicable provisions of this Indenture, and thereafter means the successor serving thereunder. 

Section 1.02 Incorporation by Reference of Trust Indenture Act. 

Whenever this Indenture refers to a provision of the TIA, the provision is incorporated by reference in and made a part of this Indenture. 

All other terms used in this Indenture that are defined by the TIA, defined by TIA reference to another statute or defined by SEC rule under
the TIA have the meanings so assigned to them. 
 Section 1.03 Rules of Construction. 

Unless the context otherwise requires: 

(a)    a term has the meaning assigned to it; 

  
 5 

 (b)    “or” is not exclusive; 

(c)    words in the singular include the plural, and in the plural include the singular; 

(d)    provisions apply to successive events and transactions; and 

(e)    references to sections of or rules under the Securities Act shall be deemed to include substitute, replacement or
successor sections or rules adopted by the SEC from time to time. 
 Section 1.04 Relationship with Base Indenture. 

The terms and provisions contained in the Base Indenture shall constitute, and are hereby expressly made, a part of this Supplemental
Indenture, and the Company and the Trustee, by their execution and delivery of this Supplemental Indenture, expressly agree to such terms and provisions and to be bound thereby. However, to the extent any provision of the Base Indenture conflicts
with the express provisions of this Supplemental Indenture, the provisions of this Supplemental Indenture shall govern and be controlling. 

ARTICLE 2 
 THE NOTES 

Section 2.01 Establishment, Form and Dating. 

(a)    There is hereby established one new series of Securities to be issued under the Base Indenture, to be designated as
the Company’s 3.550% Senior Notes due 2022. 
 (b)    There are to be authenticated and delivered $1,250,000,000
principal amount of Notes, and such principal amount of Notes may be increased from time to time pursuant to Section 2.02 of the Base Indenture by the issuance of Additional Notes. Any such Additional Notes will have the same interest rate,
maturity and other terms as the Initial Notes, except, in some cases, for their issue price and, if applicable, the initial interest accrual date and the initial interest payment date, and shall constitute a single series of Securities with the
Initial Notes; provided that if such Additional Notes are not fungible with the Initial Notes for U.S. federal income tax purposes, they will have a separate CUSIP number. No Notes shall be authenticated and delivered in addition to Notes for
the principal amount as so increased except as provided by Sections 2.09, 2.10, 2.13 or 3.08 of the Base Indenture. The Notes shall be senior debt securities and shall be issued in fully registered form. 

(c)    The Notes and the Trustee’s certificate of authentication with respect thereto will be substantially in the
form of Exhibit A hereto. The Notes may have notations, legends or endorsements required by law, stock exchange rule or usage. Each Note will be dated the date of its authentication, and except as provided in Section 2.09 of the Base
Indenture, will be issued in the form of one or more Global Notes. The principal of, and any premium or interest on, the Notes shall be payable in U.S. dollars. The Notes shall be in denominations of $2,000 and integral multiples of $1,000 in excess
thereof. 
 (d)    The terms and provisions contained in the Notes will constitute, and are hereby expressly made, a part
of the Indenture and the Company and the Trustee, by their execution and delivery of the Indenture, expressly agree to such terms and provisions and to be bound thereby. However, to the extent any provision of any Note conflicts with the express
provisions of the Indenture, the provisions of the Indenture shall govern and be controlling. 
 Section 2.02 Registrar and Paying
Agent. 
 (a)    The Company will maintain a Registrar and Paying Agent with respect to the Notes. The Registrar will
keep a register with respect to the Notes and of their transfer and exchange. 
 (b)    The Company initially appoints
The Depository Trust Company to act as Depositary with respect to the Global Notes. 

  
 6 

 (c)    The Company initially appoints the Trustee to act as the
Registrar and Paying Agent with respect to the Notes and to act as custodian for the Depositary with respect to the Global Notes. 
 ARTICLE
3 
 REDEMPTION OF NOTES 

Section 3.01 Optional Redemption. 

(a)    The Notes may be redeemed, in whole or in part, at the option of the Company pursuant to Section 3.01(b)
hereof. Other than as specifically provided in this Article 3, any redemption pursuant to this Article 3 will be made pursuant to the provisions of Article 3 of the Base Indenture. 

(b)    Prior to maturity, the Company may redeem the Notes, in whole or in part from time to time, at a redemption price
(the “Redemption Price”) equal to the greater of: (1) 100% of the principal amount of the Notes to be redeemed; and (2) as determined by the Quotation Agent, the sum of the present values of the Remaining Scheduled Payments,
discounted to the redemption date on a semi-annual basis at the Treasury Rate plus 20 basis points, plus accrued and unpaid interest thereon to, but excluding, the date of redemption. 

(c)    If the redemption date is after a record date and on or prior to a corresponding interest payment date, interest
will be paid on the redemption date to the holder of record on the record date. 
 (d)    The Redemption Price will be
calculated assuming a 360-day year consisting of twelve 30-day months. 

(e)    The Trustee shall not be responsible for the calculation of such Redemption Price. The Company shall calculate such
Redemption Price and promptly notify the Trustee in writing thereof. 
 Section 3.02 Mandatory Redemption. 

(a)    The Company is not required to make mandatory redemption or sinking fund payments with respect to the Notes. 

ARTICLE 4 
 COVENANTS 

The Notes shall be subject to the following covenants in addition to the provisions of Article 4 of the Base Indenture (provided
that Section 4.07 of the Base Indenture shall not be applicable to the Notes): 
 Section 4.01 Liens. 

The Company will not, and will not permit any of its Restricted Subsidiaries to, create, incur or assume any Lien of any kind (other than
Permitted Liens) upon any of its or their property or assets, now owned or hereafter acquired, unless all payments due under this Indenture and the Notes are secured on an equal and ratable basis with the obligations so secured until such time as
such obligations giving rise to such Lien are no longer secured by a Lien. 
 Section 4.02 Corporate Existence. 

Subject to Article 5 of the Base Indenture, the Company shall do or cause to be done all things necessary to preserve and keep in full force
and effect (i) its corporate existence in accordance with the organizational documents (as the same may be amended from time to time) of the Company and (ii) the rights (charter and statutory), licenses and franchises of the Company;
provided that the Company shall not be required to preserve any such right license or franchise if the Board of Directors shall determine that the preservation thereof is no longer desirable in the conduct of the business of the Company and
its Subsidiaries, taken as a whole, and that the loss thereof is not adverse in any material respect to the Holders of the Notes. 

  
 7 

 ARTICLE 5 

DEFEASANCE 
 Legal Defeasance of
the Notes under Section 8.04 of the Base Indenture and Covenant Defeasance of the Notes under Section 8.05 of the Base Indenture shall be applicable to the Notes, and the Company may at its option by a resolution of the Board of Directors,
at any time, with respect to the Notes, elect to have Section 8.04 or Section 8.05 of the Base Indenture be applied to the outstanding Notes upon compliance with the conditions set forth in Section 8.06 of the Base Indenture. Article
4 of this Supplemental Indenture shall be subject to Covenant Defeasance under Section 8.05 of the Base Indenture. 
 ARTICLE 6 

NO GUARANTEES 
 The provisions of
Article 10 of the Base Indenture shall be inapplicable to the Notes. 
 ARTICLE 7 

MISCELLANEOUS 
 Section 7.01
Governing Law. 
 THE INTERNAL LAW OF THE STATE OF NEW YORK WILL GOVERN AND BE USED TO CONSTRUE THIS SUPPLEMENTAL INDENTURE AND THE
NOTES WITHOUT GIVING EFFECT TO APPLICABLE PRINCIPLES OF CONFLICTS OF LAW TO THE EXTENT THAT THE APPLICATION OF THE LAWS OF ANOTHER JURISDICTION WOULD BE REQUIRED THEREBY. 

Section 7.02 Successors. 

All agreements of the Company in this Supplemental Indenture and the Notes will bind its successors. All agreements of the Trustee in this
Supplemental Indenture will bind its successors. 
 Section 7.03 Severability. 

In case any provision in this Supplemental Indenture or in the Notes is invalid, illegal or unenforceable, the validity, legality and
enforceability of the remaining provisions will not in any way be affected or impaired thereby. 
 Section 7.04 Counterpart
Originals. 
 The parties may sign any number of copies of this Supplemental Indenture. Each signed copy will be an original, but all of
them together represent the same agreement. The exchange of copies of this Supplemental Indenture and of signature pages by facsimile or .pdf transmission shall constitute effective execution and delivery of this instrument as to the parties hereto
and may be used in lieu of the original instrument for all purposes. Signatures of the parties hereto transmitted by facsimile or .pdf shall be deemed to be their original signatures for all purposes. 

  
 8 

 Section 7.05 Table of Contents, Headings, Etc. 

The Table of Contents and headings of the Articles and Sections of this Supplemental Indenture have been inserted for convenience of reference
only, are not to be considered a part of this Indenture and will in no way modify or restrict any of the terms or provisions hereof. 

[Signature Pages Follow] 

  
 9 

 IN WITNESS WHEREOF, the parties hereto have caused this Supplemental Indenture to be duly
executed as of the date set forth above. 
  

			
	GENERAL MOTORS FINANCIAL COMPANY, INC.
		
	By:	 	/s/ Richard A. Gokenbach, Jr.

 
			
	Name:	 	Richard A. Gokenbach, Jr.
	Title:	 	Executive Vice President and Treasurer

 [Signature Page to Supplemental Indenture] 

 
			
	WELLS FARGO BANK, NATIONAL ASSOCIATION,
	as Trustee
		
	By:	 	/s/ Gregory S. Clarke

 
			
	Name:	 	Gregory S. Clarke
	Title:	 	Vice President

 [Signature Page to Supplemental Indenture] 

 Exhibit A 

THIS DEBT SECURITY IS A GLOBAL SECURITY WITHIN THE MEANING OF THE INDENTURE HEREINAFTER REFERRED TO AND IS REGISTERED IN THE NAME OF A DEPOSITARY OR A
NOMINEE THEREOF. THIS DEBT SECURITY MAY NOT BE TRANSFERRED TO, OR REGISTERED OR EXCHANGED FOR SECURITIES REGISTERED IN THE NAME OF, ANY PERSON OTHER THAN THE DEPOSITARY OR A NOMINEE THEREOF, AND NO SUCH TRANSFER MAY BE REGISTERED, EXCEPT IN THE
LIMITED CIRCUMSTANCES DESCRIBED IN THE INDENTURE. EVERY DEBT SECURITY AUTHENTICATED AND DELIVERED UPON REGISTRATION OF TRANSFER OF, OR IN EXCHANGE FOR OR IN LIEU OF, THIS DEBT SECURITY SHALL BE A GLOBAL SECURITY SUBJECT TO THE FOREGOING, EXCEPT IN
SUCH LIMITED CIRCUMSTANCES. 
 UNLESS THIS GLOBAL SECURITY IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY, A NEW YORK
CORPORATION (“DTC”), TO GENERAL MOTORS FINANCIAL COMPANY, INC. OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF CEDE & CO. OR IN SUCH OTHER NAME AS IS
REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC (AND ANY PAYMENT IS MADE TO CEDE & CO. OR TO SUCH OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC), ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR
TO ANY PERSON IS WRONGFUL INASMUCH AS THE REGISTERED OWNER HEREOF, CEDE & CO., HAS AN INTEREST HEREIN.1 

BY ITS ACQUISITION AND HOLDING OF THIS DEBT SECURITY, THE HOLDER THEREOF WILL BE DEEMED TO HAVE REPRESENTED AND WARRANTED THAT EITHER (1) THE HOLDER
IS NOT ACQUIRING OR HOLDING THE SECURITY FOR OR ON BEHALF OF, AND NO PORTION OF THE ASSETS USED BY SUCH HOLDER TO ACQUIRE OR HOLD THIS SECURITY, OR ANY INTEREST THEREIN, CONSTITUTES THE ASSETS OF AN EMPLOYEE BENEFIT PLAN THAT IS SUBJECT TO TITLE I
OF THE U.S. EMPLOYEE RETIREMENT INCOME SECURITY ACT OF 1974, AS AMENDED (“ERISA”), A PLAN, INDIVIDUAL RETIREMENT ACCOUNT OR OTHER ARRANGEMENT THAT IS SUBJECT TO SECTION 4975 OF THE U.S. INTERNAL REVENUE CODE OF 1986, AS AMENDED (THE
“CODE”) OR PROVISIONS UNDER ANY OTHER FEDERAL, STATE, LOCAL, NON-U.S. OR OTHER LAWS OR REGULATIONS THAT ARE SIMILAR TO SUCH PROVISIONS OF ERISA OR THE CODE (COLLECTIVELY, “SIMILAR LAWS”),
OR OF AN ENTITY WHOSE UNDERLYING ASSETS ARE CONSIDERED TO INCLUDE “PLAN ASSETS” OF ANY SUCH PLAN, ACCOUNT OR ARRANGEMENT, OR (2) THE ACQUISITION, HOLDING, AND SUBSEQUENT DISPOSITION OF THIS SECURITY WILL NOT CONSTITUTE A NON-EXEMPT PROHIBITED TRANSACTION UNDER SECTION 406 OF ERISA OR SECTION 4975 OF THE CODE OR A SIMILAR VIOLATION UNDER ANY APPLICABLE SIMILAR LAWS. 

 

	(1) 	 Insert in Global Notes only. 

			
	 CUSIP No.:    
	  	37045X CU8
	 ISIN No.:
	  	US37045XCU81

 3.550% Senior Notes due 2022 
  

			
	No. R-[    ]	  	$[                ]

 GENERAL MOTORS FINANCIAL COMPANY, INC. promises to pay to [CEDE & CO.]2 or registered assigns, the principal sum of $[                ][(subject to the decreases and increases
in principal amount set forth on the Schedule of Exchanges of Interests in the Global Note attached hereto)]3 on July 8, 2022. 

Interest Payment Dates: January 8 and July 8, commencing July 8, 2019. 

Record Dates: 15 calendar days prior to each Interest Payment Date. 

 

	2 	 Insert in Global Notes only. 

	3 	 Insert in Global Notes only. 

  
 A-2 

 Dated: 
  

			
	GENERAL MOTORS FINANCIAL COMPANY, INC.
		
	By:	 	            

 
			
	Name:	 	Richard A. Gokenbach, Jr.
	Title:	 	Executive Vice President and Treasurer

  
 A-3 

 This is one of the Global 

Notes referred to in the 
 within-mentioned Indenture: 

Dated: 
  

			
	WELLS FARGO BANK, NATIONAL ASSOCIATION
	as Trustee
		
	By:	 	            

			
	Name:	 	Gregory S. Clarke
	Title:	 	Vice President

  
 A-4 

 [Back of Note] 

3.550% Senior Note due 2022 

This Note is one of a duly authorized issue of Securities of General Motors Financial Company, Inc. (the “Company,” which
term includes any successor Person under the Base Indenture hereinafter referred to), issued and issuable in one or more series under an indenture, dated as of October 13, 2015 (as amended or supplemented to the date hereof, the “Base
Indenture”), between the Company and Wells Fargo Bank, National Association, as trustee (the “Trustee,” which term includes any successor trustee under the Base Indenture), to which Base Indenture and all indentures
supplemental thereto reference is hereby made for a statement of the respective rights, limitation of rights, duties and immunities thereunder of the Company, the Trustee and the Holders of the Securities issued thereunder and of the terms upon
which said Securities are, and are to be, authenticated and delivered. This Note is one of the series designated on the face hereof as 3.550% Senior Notes due 2022 (the “Notes”), which was issued under the Thirty-Fifth Supplemental
Indenture, dated as of April 8, 2019, to the Base Indenture (the “Supplemental Indenture” and, together with the Base Indenture, the “Indenture”) and which is initially limited to $1,250,000,000 in principal
amount. Capitalized terms used herein for which no definition is provided herein shall have the meanings set forth in the Indenture. 

1.    INTEREST. The Notes will bear interest at 3.550% per annum. The Company will pay interest semi-annually in
arrears on January 8 and July 8 of each year, commencing on July 8, 2019, and at maturity. If any Interest Payment Date, stated maturity date or earlier redemption date for the Notes is not a Business Day, the Company will make the
required payment of principal, premium, if any, and interest, if any, on the next succeeding Business Day, and no interest will accrue on the amount so payable for the intervening period. Interest on the Notes will accrue from and including the most
recent date to which interest has been paid or, if no interest has been paid, from April 8, 2019; provided that if there is no existing Default in the payment of interest, and if this Note is authenticated between a record date referred
to on the face hereof and the next succeeding Interest Payment Date, interest shall accrue from such next succeeding Interest Payment Date; provided, further, that the first Interest Payment Date shall be July 8, 2019. The Company
shall pay interest (including post-petition interest in any proceeding under any Bankruptcy Law) on overdue principal and premium, if any, from time to time on demand at a rate that is 1% per annum in excess of the rate then in effect; it shall pay
interest (including post-petition interest in any proceeding under any Bankruptcy Law) on overdue installments of interest from time to time on demand at the same rate to the extent lawful. Interest will be computed on the basis of a 360-day year of twelve 30-day months. 

2.    METHOD OF PAYMENT. The Company will pay interest on the Notes (except defaulted interest) to the Persons who
are registered Holders of Notes at the close of business on the record date on the next preceding Interest Payment Date, even if such Notes are cancelled after such record date and on or before such Interest Payment Date, except as provided in
Section 2.08 of the Indenture with respect to defaulted interest. The Notes will be payable as to principal, premium, if any, and interest, if any, at the office or agency of the Trustee maintained for such purpose within the City and State of
New York. The Company will make payments of principal, premium, if any, and interest, if any, in respect of the Notes in book-entry form to the Depositary in immediately available funds, while disbursement of such payments to owners of beneficial
interests in Notes in book-entry form will be made in accordance with the procedures of the Depositary and its participants in effect from time to time. 

3.    PAYING AGENT AND REGISTRAR. Initially, Wells Fargo Bank, National Association, the Trustee under the
Indenture, will act as Paying Agent and Registrar. The Company may change any Paying Agent or Registrar without notice to any Holder. The Company or any of its Subsidiaries may act in any such capacity. 

  
 A-5 

 4.    INDENTURE. The Company issued the Notes under the
Indenture. The terms of the Notes include those stated in the Indenture and those made part of the Indenture by reference to the TIA. The Notes are subject to all such terms, and Holders are referred to the Indenture and the TIA for a statement of
such terms. To the extent any provision of this Note conflicts with the express provisions of the Indenture, the provisions of the Indenture shall govern and be controlling. The Notes are general unsecured obligations of the Company and are not
limited as to aggregate principal amount. The Notes, including any Additional Notes issued hereunder, shall contain the terms set forth herein and in the Indenture and shall constitute and be treated as one series of Notes for all purposes. 

5.    OPTIONAL REDEMPTION. The Notes are subject to redemption as provided in Article 3 of the Indenture.

 6.    MANDATORY REDEMPTION. The Company shall not be required to make mandatory redemption payments with
respect to the Notes. 
 7.    DENOMINATIONS, TRANSFER, EXCHANGE. The Notes are in registered form without coupons
in denominations of $2,000 and integral multiples of $1,000 in excess thereof. The transfer of Notes may be registered and Notes may be exchanged as provided in the Indenture. The Registrar and the Trustee may require a Holder, among other things,
to furnish appropriate endorsements and transfer documents, and the Company may require a Holder to pay any taxes and fees required by law or permitted by the Indenture. The Company need not exchange or register the transfer of any Note or portion
of a Note selected for redemption, except for the unredeemed portion of any Note being redeemed in part. Also, it need not exchange or register the transfer of any Notes for a period of 15 days before a selection of Notes to be redeemed or during
the period between a record date and the corresponding Interest Payment Date. 
 8.    PERSONS DEEMED OWNERS. The
registered Holder of a Note will be treated as its owner for all purposes. 
 9.    AMENDMENT, SUPPLEMENT AND
WAIVER. The Indenture or the Notes may be amended or supplemented as provided in Article 9 of the Base Indenture. 

10.    DEFAULTS AND REMEDIES. The terms of Article 6 of the Base Indenture shall be applicable to the Notes. 

11.    TRUSTEE DEALINGS WITH COMPANY. The Trustee, in its individual or any other capacity, may make loans to,
accept deposits from, and perform services for the Company or its Affiliates, and may otherwise deal with the Company or its Affiliates, as if it were not the Trustee. 

12.    NO RECOURSE AGAINST OTHERS. A director, officer, employee, incorporator or shareholder of the Company, as
such, shall not have any liability for any obligations of the Company under the Notes or the Indenture or for any claim based on, in respect of, or by reason of, such obligations or their creation. Each Holder by accepting a Note waives and releases
all such liability. The waiver and release are part of the consideration for the issuance of the Notes. 

13.    AUTHENTICATION. This Note shall not be valid until authenticated by the manual signature of the Trustee or an
authenticating agent. 
 14.    ABBREVIATIONS. Customary abbreviations may be used in the name of a Holder or an
assignee, such as: TEN COM (= tenants in common), TEN ENT (= tenants by the entireties), JT TEN (= joint tenants with right of survivorship and not as tenants in common), CUST (= Custodian), and U/G/M/A (= Uniform Gifts to
Minors Act). 

  
 A-6 

 15.    CUSIP NUMBERS. Pursuant to a recommendation promulgated by
the Committee on Uniform Security Identification Procedures, the Company has caused CUSIP numbers to be printed on the Notes and the Trustee may use CUSIP numbers in notices of redemption as a convenience to Holders. No representation is made as to
the accuracy of such numbers, either as printed on the Notes or as contained in any notice of redemption, and reliance may be placed only on the other identification numbers placed thereon. 

16.    NOTICES. The Company will furnish to any Holder upon written request and without charge a copy of the
Indenture. Requests may be made to: 
 General Motors Financial Company, Inc. 

801 Cherry Street, Suite 3500 

Fort Worth, Texas 76102 

Attention: Chief Financial Officer 

17.    GOVERNING LAW. THE INTERNAL LAW OF THE STATE OF NEW YORK WILL GOVERN AND BE USED TO CONSTRUE THIS NOTE AND
THE INDENTURE WITHOUT GIVING EFFECT TO APPLICABLE PRINCIPLES OF CONFLICTS OF LAW TO THE EXTENT THAT THE APPLICATION OF THE LAWS OF ANOTHER JURISDICTION WOULD BE REQUIRED THEREBY. 

  
 A-7 

 Assignment Form 

To assign this Note, fill in the form below: (I) or (we) assign and transfer this Note to: 

 
  

(Insert assignee’s soc. sec. or tax I.D. no.) 
  

 
  

 
  

 
 (Print or type assignee’s name,
address and zip code) 
 and irrevocably
appoint:                                     

to transfer this Note on the books of the Registrar. The agent may substitute another to act for him. 

Date:
                                         
        
 Your
Signature:                                       
                              

(Sign exactly as your name appears on the face of this Note) 

  
 A-8 

 SCHEDULE OF EXCHANGES OF INTERESTS IN THE GLOBAL NOTE 

The following exchanges of a part of this Global Note for an interest in another Global Note or for a Definitive Note, or exchanges of a part
of another Global Note or Definitive Note for an interest in this Global Note, have been made: 
  

									
	 Date of Exchange
	 	 Amount of Decrease

in Principal Amount

of this Global Note
	 	 Amount of Increase

in Principal Amount

of this Global Note
	  	 Principal Amount

of this Global Note

Following Such
Decrease (or Increase)
	  	 Signature of Authorized
Officer of
Trustee or
Note Custodian

		 		 		  		  	

  
 A-9

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00294-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00294-of-00352.parquet"}]]